Schonfeld Strategic Advisors LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2023$3,132,608
+79.7%
69,629
+162.9%
0.03%
+100.0%
Q3 2022$1,743,000
-14.4%
26,484
+33.6%
0.02%
-28.6%
Q3 2021$2,037,000
-33.1%
19,818
-27.0%
0.02%
-48.8%
Q4 2020$3,044,000
+411.6%
27,137
+323.0%
0.04%
+272.7%
Q3 2020$595,000
+141.9%
6,415
+108.7%
0.01%
+83.3%
Q4 2019$246,000
-90.1%
3,074
-90.9%
0.01%
-91.8%
Q3 2019$2,484,000
-81.6%
33,800
-76.4%
0.07%
-84.8%
Q2 2019$13,536,000
+38.6%
143,500
+17.6%
0.48%
+41.3%
Q1 2019$9,766,000
+853.7%
122,000
+797.9%
0.34%
+303.6%
Q4 2017$1,024,000
+43.4%
13,588
-23.9%
0.08%
+16.7%
Q1 2017$714,00017,8490.07%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders